Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-26

Clinical Trial Update: The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial [NA]

View source ↗

Summary

A completed multi-center randomized open-label trial evaluating the curative effect of combining entecavir with resveratrol in hepatitis B patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baraclude (entecavir)
  • Resveratrol (resveratrol)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Hepatitis | NA | Status: COMPLETED